All Reports Events Blogs Videos
Showing 13 results
  • Innovation Watch
    Sep. 28, 2026

    Agentic AI is becoming a significant driver for life sciences commercial organizations seeking to improve productivity, customer engagement, and decision-making across increasingly complex workflows. Commercial teams are exploring its use across product launch, pricing and market…
  • Tech Provider Spotlight
    March 19, 2026

    Life sciences commercial engagement is undergoing a fundamental transformation as enterprises move from siloed, channel-centric models to coordinated, customer-centric omnichannel strategies. Increasing Healthcare Professionals (HCP) access constraints, evolving customer expectations, proliferation of digital channels, and mounting…
  • Provider Compendium
    Aug. 19, 2025

    Life sciences enterprises are reassessing how they engage with healthcare professionals and patients amid growing emphasis on hybrid commercial models and personalized experiences. This shift is prompting greater interest in next-generation Customer Engagement Platforms (CEPs) that…
  • Viewpoint
    Aug. 11, 2025

    Pharma enterprises have reached an inflection point in the CRM platform landscape, driven by the dissolution of the Veeva-Salesforce partnership and rising expectations for connected, personalized interactions across all commercial functions. Traditional CRM systems, built primarily…
  • PEAK Matrix®
    July 31, 2025

    Life sciences enterprises are expanding their use of Veeva Vault across regulated functions, including clinical operations, regulatory information management, quality systems, promotional content management, and CRM. As adoption moves beyond single modules to integrated, cross-Vault deployments,…
  • PEAK Matrix®
    Nov. 07, 2024

    Life sciences companies must engage customers effectively to drive business success through differentiated experiences. Hybrid commercial models require seamless, personalized interactions across channels to serve healthcare providers and patients. Advanced Customer Engagement Platforms (CEPs) go beyond…
  • Provider Compendium
    Sep. 20, 2022

    Life Sciences (LS) Operations – Service Provider Compendium provides accurate, comprehensive, and fact-based snapshots of 31 providers, including their scale of operations, technology solutions, and delivery locations, along with Everest Group’s PEAK Matrix® provider assessment. The…
  • PEAK Matrix®
    June 23, 2022

    Following the COVID-19 pandemic, the life sciences industry has undergone several changes. Face-to-face HCP interactions are slowly being replaced with an omnichannel approach; the market is also pivoting from centralized clinical trials to de-centralized clinical trial…
  • PEAK Matrix®
    June 28, 2021

    The life sciences industry has been severely impacted by the COVID-19 pandemic, with hundreds of clinical trials halted and most ongoing trials disrupted in one way or the other. In the wake of this disruption, enterprises…
  • State of the Market
    Dec. 18, 2020

    The healthcare provider industry has been plagued with numerous issues – care providers have been operating on thin margins due to high claims denials, increasing bad debts, and the higher cost of operations, partially because of…
  • Provider Compendium
    March 13, 2020

    The Life Sciences (LS) Operations – Service Provider Compendium provides accurate, comprehensive, and fact-based snapshots of 24 service providers. In particular, it helps current and potential buyers of LS services assess providers on their areas of…
  • PEAK Matrix®
    Dec. 13, 2019

    As we enter a new decade, the global life sciences industry is undergoing momentous changes and facing major headwinds including continued M&As, decline in blockbuster drugs and shift towards specialty drugs (including orphan drugs and personalized…